IRIS
CAGNETTA, ANTONIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.993
AS - Asia 759
NA - Nord America 753
Continente sconosciuto - Info sul continente non disponibili 110
SA - Sud America 66
AF - Africa 12
OC - Oceania 5
Totale 7.698
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.841
US - Stati Uniti d'America 699
SG - Singapore 272
CN - Cina 174
BD - Bangladesh 135
VN - Vietnam 122
FR - Francia 43
BR - Brasile 34
FI - Finlandia 24
HK - Hong Kong 24
CA - Canada 23
DE - Germania 23
AR - Argentina 16
GB - Regno Unito 14
IQ - Iraq 7
MX - Messico 7
NL - Olanda 7
IN - India 6
CH - Svizzera 5
EC - Ecuador 5
ES - Italia 5
MA - Marocco 5
UA - Ucraina 5
AU - Australia 4
HN - Honduras 4
ID - Indonesia 4
JP - Giappone 4
PY - Paraguay 4
AT - Austria 3
BB - Barbados 3
CO - Colombia 3
GR - Grecia 3
IE - Irlanda 3
JM - Giamaica 3
NI - Nicaragua 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
CR - Costa Rica 2
KR - Corea 2
PL - Polonia 2
PT - Portogallo 2
RO - Romania 2
SE - Svezia 2
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
CU - Cuba 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GT - Guatemala 1
HR - Croazia 1
KE - Kenya 1
LB - Libano 1
LT - Lituania 1
MG - Madagascar 1
MT - Malta 1
PF - Polinesia Francese 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TR - Turchia 1
TW - Taiwan 1
TZ - Tanzania 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 7.588
Salva come PNG Salva come JPEG
Città #
Genova 3.163
Genoa 1.710
Rapallo 484
Vado Ligure 350
San Jose 162
Singapore 140
Ashburn 85
Ho Chi Minh City 41
Lauterbourg 38
Beijing 35
New York 32
Hanoi 25
Helsinki 24
Hong Kong 24
Los Angeles 22
Frankfurt am Main 19
Council Bluffs 16
Santa Clara 16
Chicago 13
Phoenix 13
Milan 11
Buffalo 10
Columbus 9
Bordighera 8
Da Nang 7
Rome 7
Dallas 6
Florence 6
Montreal 6
The Dalles 6
Tianjin 6
Turin 6
Denver 5
Haiphong 5
London 5
Naples 5
Zurich 5
Amsterdam 4
Boardman 4
Brooklyn 4
Miami 4
Perugia 4
Tokyo 4
Washington 4
Athens 3
Biên Hòa 3
Bridgetown 3
Cardiff 3
Charlotte 3
City of London 3
Kyiv 3
Lansdowne 3
Las Vegas 3
Madrid 3
Managua 3
Memphis 3
Nha Trang 3
Orem 3
Palermo 3
Paris 3
Parma 3
San Salvador 3
Sydney 3
São Paulo 3
Toronto 3
Albany 2
Baton Rouge 2
Belo Horizonte 2
Bologna 2
Bountiful 2
Boydton 2
Brasília 2
Bắc Ninh 2
Can Tho 2
Casablanca 2
Chennai 2
Chesapeake 2
Citrus Heights 2
Ciudad del Este 2
Clinton 2
Dublin 2
Endicott 2
Greensboro 2
Hewitt 2
Hohenwald 2
Houston 2
Hải Dương 2
Ilion 2
Jacksonville 2
Janesville 2
Lambaré 2
Mattoon 2
Mexico City 2
Milwaukee 2
Nashville 2
Neu-Ulm 2
Newark 2
Ninh Bình 2
Nuremberg 2
Orlando 2
Totale 6.686
Salva come PNG Salva come JPEG
Nome #
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 329
APO866 activity in hematologic malignancies: a preclinical in vitro study. 256
APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment 255
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells vulnerability to DNA-damaging agents 253
Nicotinic acid phosphoribosyltransferase regulates cancer cell metabolism, susceptibility to NAMPT inhibitors and DNA repair. 249
A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia 231
Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas 216
Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity. 212
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 206
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 198
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 193
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information 192
Evaluating treatment response of chronic myeloid leukemia: emerging science and technology. 185
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 183
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents 182
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 182
The new small tyrosine-kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs 182
NAD+ METABOLISM RESTRICTION BOOSTS HIGH-DOSE MELPHALAN EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA 181
Nicotinamide Phosphoribosyltransferase As A Target In Inflammation-Related Disorders. 173
Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD-driven salvage approach 173
Dual NAMPT and BTK targeting leads to synergistic killing of Waldenström macroglobulinemia cells regardless of MYD88 and CXCR4 somatic mutation status 173
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 168
Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogenetics. 167
Exploiting tumor vulnerabilities: NAD+-depleting agents combined with anti-tumor drugs as innovative strategy to treat hematological malignancies 167
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma 162
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 159
New insights into biology of chronic myeloid leukemia: implications in therapy. 159
Targeting NAD(+) Salvage Pathway Induces Autophagy in Multiple Myeloma Cells 158
CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: Molecular mechanisms and therapeutic implications 155
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib 155
Targeting NAD+ Salvage Pathway Induces Autophagy in Multiple Myeloma Cells via mTORC1 and Extracellular Signal-Regulated Kinase (ERK1/2) Inhibition 153
New insights into the treatment of multiple myeloma with histone deacetylase inhibitors. 148
Intracellular NAD⁺ depletion enhances bortezomib-induced anti-myeloma activity. 145
WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia. 141
SIRT6 inhibition as a novel approach for treating Acute Myeloid Leukemia 137
MiR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth 134
Intracellular NAD+ depletion induces autophagic-death in Multiple Myeloma cells 131
Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma 129
A Blastic Plasmacytoid Dendritic Cell Neoplasm-like Phenotype Identifies a Subgroup of NPM1-Mutated AML Patients with Worse Prognosis While Has Not Predictive Value in NPM1-Wt AML 121
Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells 119
Synergistic Interaction Between P-glycoprotein Inhibitors and APO866 in Primary Leukemic Cells 115
Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation 103
Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma 82
Mechanisms and Clinical Applications of Genome Instability in Multiple Myeloma 81
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information 73
Partial Inhibition Of Nampt Restores Metabolic Vulnerability And Synergizes With Anti-Myeloma Agents In Multiple Myeloma 32
Totale 7.698
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.546
article - articoli 24.546
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.092
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022501 0 0 37 69 24 44 30 109 28 47 29 84
2022/2023601 67 67 3 73 97 86 6 37 85 12 64 4
2023/2024391 13 53 14 50 41 80 22 38 10 5 28 37
2024/20251.047 38 64 29 74 96 99 107 230 33 46 106 125
2025/20262.070 234 52 103 207 241 149 273 83 154 184 210 180
2026/2027329 179 77 73 0 0 0 0 0 0 0 0 0
Totale 7.698